5 Massachusetts Biotechs That Tanked More Than 60% in 2017 Post author:Sam Post published:January 1, 2018 Post category:BioPharma This is definitely a list few, if any, companies want to be on. Source: BioSpace You Might Also Like Debt-Laden Valeant Unloads iNova Pharma In $930 Million Deal June 7, 2017 Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents November 21, 2017 Meet Man in the Lab at the March 6, 2017
